The Employees' State Insurance Corporation (ESIC) on March 10, 2026, issued issued amendment in Brand name for Item no.322 in DGESIC RC-155 and Item no. 2076 in DGESIC RC-160 in r/o M/s. Bajaj Healthcare Limited.
The drug supplied by M/s. Bajaj Healthcare Limited shall continue to adhere to composition, strength, etc as approved under the respective DGESIC Rate Contract & conform to the standards and specifications as per the Drug & Cosmetic Act and any amendments thereof.
The aforesaid amendment has been given in the track mode.
Kindly find the document below.
[File no. U-25/12/RC/Amendment/Dosage/Misc/2025-Med.V (E:1237671)/72]
